Description
A prodrug from of ulifloxacin; increases survival in various mouse models of systemic bacterial infection (ED50s = 0.35-23 mg/kg); increases survival in a mouse model of K. pneumoniae-induced respiratory tract infection (ED50 = 0.981 mg/kg)
Formal name: 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
Synonyms: NM441
Molecular weight: 461.5
CAS: 123447-62-1
Purity: ≥98%
Formulation: A crystalline solid